Explore
UroGen Pharma LtdURGN
$31.29+5.04%24H
URGN / USDNASDAQ
Use arrow keys to change the interval
Equity Info
P/E Ratio—
Market Cap$1.25B
EPS-1.31
52 Week Range$16.50 - $50.81
Volume$312.90
Liquidity Score—
About UroGen Pharma Ltd

UroGen Pharma Ltd (URGN) is an innovative biotechnology company focused on the development of advanced therapies for urological diseases, including urothelial carcinoma and bladder cancer. Leveraging its proprietary reverse thermal gel technology, the company enables targeted, sustained drug delivery, maximizing treatment efficacy while reducing systemic side effects. UroGen's strong clinical pipeline underscores its commitment to addressing substantial unmet medical needs in the oncology space, positioning the company as a potential leader in the urological oncology market and significantly improving patient outcomes.

HeadquartersPRINCETON, NJ

Buy

—
—

Assets

Asset
UroGen Pharma Ltd
rURGN
Reality Finance
Trending
ROKU
Roku Inc
$160.540.07%
No chart data availableHistorical price data isn't available for this asset yet.
Details
KVUE
Kenvue Inc.
$19.271.53%
No chart data availableHistorical price data isn't available for this asset yet.
Details
URI
United Rentals Inc
$1,090.990.33%
Details

Help